RTI Surgical Inc., a leading global surgical implant company, announced a new agreement with Oxford Performance Materials, Inc. (OPM), a pioneer in advanced materials and additive manufacturing (3-D printing) for Biomedical Applications. The agreement, effective from Feb. 4, 2016, grants RTI an exclusive license to OPM’s OsteoFab^® technology platform for Spinal Applications in all U.S. market.

Oxford Performance Materials Inc., a Connecticut-based company known for its 3D Printed Implants close to bones with osteoconductive properties and PEKK, has recently been accredited as a foreign medical device manufacturer by the Japanese Ministry of Health, Labour, and Welfare. Now able to serve over 14 countries of Asia in a partnership with JSR Corp. of Tokyo, OPM looks forward to expanding the reach of 3D Printing to far horizons.